In Vitro Diagnostics Quality Controls Market Revenue to Attain USD 1.94 Bn by 2035
Published: 11 Mar 2026
Author: Precedence Research
In Vitro Diagnostics Quality Controls Market Revenue and Trends 2026 to 2035
The global in vitro diagnostics quality controls market revenue was valued at USD 1.41 billion in 2025 and is expected to attain around USD 1.94 billion by 2035, growing at a CAGR of 3.24% during forecast period. The market is driven by increasing demand for high-precision results, rising volumes of complex diagnostic tests, and stringent regulations on patient safety.
What are the Major Driving Factors of the In Vitro Diagnostics Quality Controls Market?
The market is expanding rapidly due to growing demand for accurate diagnostic test results in the face of increasing chronic diseases, the rising geriatric population, and technological advances in diagnostic processes. The focus on reducing diagnostic errors through automated, high-throughput instruments continues to drive global market growth. Additionally, the adoption of AI with advanced software is gaining popularity, enabling better monitoring and helping to prevent human errors.
Segment Insights
- By Product and Services, The quality control products segment held the largest market share of 56% in 2025 due to their diverse application in clinical labs to ensure testing accuracy, equipment performance, and regulatory compliance.
- By Manufacturer Type, The third-party control segment held the largest market share of 58% in 2025, as it offers unbiased and independent quality verification to ensure reliability and greater accuracy.
- By Technology, The Immunoassay diagnostics segment held the largest market share of 29% in 2025 due to the growing volume of testing and the diverse applications of immunoassays in food safety, environmental monitoring, and clinical diagnosis to find various chronic diseases.
- By Application, The infectious disease testing segment held the largest market share of nearly 27% in 2025 due to the increasing demand for precise diagnosis for better results and growing adoption of molecular diagnostic technology in laboratories to deal with the increasing infectious diseases.
- By End User, The hospitals segment held the largest market share in 2025 as they offer standard equipment and a wide range of blood tests, even with a large volume of testing in several sectors like molecular diagnostics and hematology.
Regional Insights
North America held the largest market share of nearly 41% in 2025, driven by factors such as its well-developed healthcare infrastructure, advanced laboratory facilities, and the rapid integration of innovative diagnostic technologies across hospitals and clinical laboratories. Healthcare institutions in the region are increasingly adopting advanced quality control (QC) solutions and laboratory information management systems (LIMS) introduced by leading companies to ensure accurate and reliable diagnostic results. The strong presence of major diagnostic manufacturers, continuous technological advancements, and strict regulatory frameworks focused on patient safety further support the growth of the in vitro diagnostics quality controls market in North America.
Asia Pacific is expected to witness the fastest CAGR during the forecast period, owing to the growing consumer preference for independently visiting diagnostic laboratories for healthcare parameter testing through blood samples. The increasing awareness of preventive healthcare and early disease detection is encouraging individuals to undergo regular diagnostic tests, which is boosting demand for reliable quality control solutions. In addition, many QC centers and diagnostic laboratories are increasingly adopting advanced QC software to ensure precise and accurate test results.
In Vitro Diagnostics Quality Controls Market Coverage
| Report Attribute | Key Statistics |
| Market Revenue in 2025 | USD 1.41 Billion |
| Market Revenue by 2035 | USD 1.94 Billion |
| CAGR from 2026 to 2035 | 3.24% |
| Quantitative Units | Revenue in USD million/billion, Volume in units |
| Largest Market | North America |
| Base Year | 2025 |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa |
Recent Development
- In August 2025, a global leader in in vitro diagnostics, ‘bioMérieux,’ announced the new launch of its first DNA-based test, GENE-UP PRO HRM, which is commercially developed to find heat-resistant molds at the molecular level.(Source: https://www.prnewswire.com)
Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/7971
You can place an order or ask any questions, please feel free to contact us at sales@precedenceresearch.com |+1 804 441 9344